Hanmi Pharmaceutical Co., Ltd.

Insider Reports History

Entity
Company
Location
14, Wiryeseong Daero, Songpa Gu, Seoul, Korea, Republic of
Signature
HANMI PHARMACEUTICAL CO., LTD.; By: /s/ Haegon Shin, Managing Director, Global Business Division
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hanmi Pharmaceutical Co., Ltd.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aptose Biosciences Inc. 10%+ Owner Common Shares 509K $102K $0.20 Mar 18, 2025 Direct

Insider Reports Filed by Hanmi Pharmaceutical Co., Ltd.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APTO Aptose Biosciences Inc. Mar 18, 2025 0 $0 3 Mar 20, 2025 10%+ Owner